Related references
Note: Only part of the references are listed.Learning from the past: development of safe and effective COVID-19 vaccines
Shan Su et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Significantly Decreased Mortality in a Large Cohort of Coronavirus Disease 2019 (COVID-19) Patients Transfused Early with Convalescent Plasma Containing High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein IgG
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
Peter Chen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Signals of Th2 immune response from COVID-19 patients requiring intensive care
Luca Roncati et al.
ANNALS OF HEMATOLOGY (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Identification of Human Single-Domain Antibodies against SARS-CoV-2
Yanling Wu et al.
CELL HOST & MICROBE (2020)
Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019
Xiaohua Chen et al.
CLINICAL INFECTIOUS DISEASES (2020)
Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses
Ning Wang et al.
FRONTIERS IN MICROBIOLOGY (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
Human neutralizing antibodies elicited by SARS-CoV-2 infection
Bin Ju et al.
NATURE (2020)
Cross-neutralization ofSARS-CoV-2 by a human monoclonal SARS-CoV antibody
Dora Pinto et al.
NATURE (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
Michael J. Joyner et al.
MAYO CLINIC PROCEEDINGS (2020)
High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models
Wei Li et al.
CELL (2020)
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu et al.
NATURE (2020)
Potently neutralizing and protective human antibodies against SARS-CoV-2
Seth J. Zost et al.
NATURE (2020)
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiangdong Huo et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model
Thomas F. Rogers et al.
SCIENCE (2020)
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial
Christina M. Eckhardt et al.
TRIALS (2020)
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial
Jonathan Rilinger et al.
TRIALS (2020)
Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
Sean T. H. Liu et al.
NATURE MEDICINE (2020)
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial
Aoife Cotter et al.
TRIALS (2020)
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
Liqiang Feng et al.
NATURE COMMUNICATIONS (2020)
An alpaca nanobody neutralizes SARS-CoV-2 by blocking receptor interaction
Leo Hanke et al.
NATURE COMMUNICATIONS (2020)
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
Xiaojing Chi et al.
NATURE COMMUNICATIONS (2020)
Convalescent plasma is ineffective for covid-19 Lessons from the Placid Trial
Elizabeth B. Pathak
BMJ-BRITISH MEDICAL JOURNAL (2020)
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Anup Agarwal et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike
Michael Schoof et al.
SCIENCE (2020)
Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Yufei Xiang et al.
SCIENCE (2020)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response
Meagan Bolles et al.
JOURNAL OF VIROLOGY (2011)
The spike protein of SARS-CoV - a target for vaccine and therapeutic development
Lanying Du et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcγRII- dependent entry into B cells in vitro
Yin Wing Kam et al.
VACCINE (2007)
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
M Czub et al.
VACCINE (2005)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)